A new prostate cancer treatment has been reported to reduce the risk of side-effects associated with more conventional therapies, drawing attention after it emerged that broadcaster Jeremy Clarkson had used the treatment himself. The development is significant because prostate cancer therapies, including surgery and radiotherapy, are commonly associated with side-effects such as incontinence and erectile dysfunction, so a treatment offering a lower risk profile could represent a meaningful improvement for patients weighing up their options.

The article's full details on the specific therapy, how it works and the clinical evidence behind it were not available in the retrieved text, which consisted mainly of unrelated site navigation and headlines rather than the article body. The core reported fact is that this newer approach has been linked to Clarkson's own treatment experience and is being highlighted for its reduced side-effects risk compared with standard options.